{
    "title": "112_hr2695",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Trisomy 21 Research Centers of \nExcellence Act of 2011''.\n\nSEC. 2. NIH DOWN SYNDROME RESEARCH ACTIVITIES.\n\n    Part B of title IV of the Public Health Service Act (42 U.S.C. 284 \net seq.) is amended by adding at the end of the title the following:\n\n``SEC. 409K. DOWN SYNDROME RESEARCH ACTIVITIES.\n\n    ``(a) Expansion, Intensification, and Coordination of Activities.--\n            ``(1) In general.--The Director of NIH, acting through the \n        Director of the Eunice Kennedy Shriver National Institute of \n        Child Health and Human Development, shall expand and intensify \n        programs of the National Institutes of Health with respect to \n        research and related activities concerning Down syndrome. The \n        Director of NIH shall carry out such programs in coordination \n        with a working group composed of representatives of the \n        relevant institutes, centers, offices, and agencies of the \n        National Institutes of Health.\n            ``(2) NIH research plan on down syndrome.--The Director of \n        NIH shall publish a research plan on Down syndrome, and update \n        it every 5 years or as appropriate.\n    ``(b) Centers of Excellence.--\n            ``(1) In general.--In carrying out subsection (a)(1), the \n        Director of NIH shall award grants and contracts to public or \n        nonprofit private entities to pay all or part of the cost of \n        planning, establishing, improving, and providing basic \n        operating support for centers of excellence regarding \n        translational research on Down syndrome. To the extent and in \n        the amount of appropriations made in advance, the Director of \n        NIH shall provide for the establishment of at least 6 such \n        centers of excellence.\n            ``(2) Basic, translational, and clinical research.--Each \n        center receiving funds under paragraph (1) shall contribute to \n        a comprehensive research portfolio for Down syndrome building \n        upon the recommendations set forth in the NIH Research Plan on \n        Down Syndrome published on October 8, 2007, have a primary \n        focus on Down syndrome, provide an optimal venue and \n        infrastructure for patient-oriented research, and conduct \n        basic, clinical, and translational research on Down syndrome, \n        including research on one or more of the following:\n                    ``(A) Early detection, diagnosis, and treatment of \n                Down syndrome.\n                    ``(B) The biological mechanisms responsible for \n                structural and functional anomalies in cells and \n                tissues affected by Down syndrome.\n                    ``(C) The biological mechanisms responsible for \n                cognitive and behavioral dysfunction resulting from \n                Down syndrome.\n                    ``(D) Novel biomedical and pharmacological \n                interventions designed to promote or enhance cognition \n                and related brain functions and activities of daily \n                living (ADLs).\n                    ``(E) Co-occurrence of and treatments for \n                associated medical and neurobehavioral disorders.\n                    ``(F) Developmental disorders, interventions for \n                congenital heart disease, obstructive sleep apnea, \n                coronary heart disease, obesity, and metabolism.\n                    ``(G) Contributions of genetic variation to \n                clinical presentation as targets for therapy.\n                    ``(H) Identification of biomarkers for complex \n                phenotypes.\n                    ``(I) Noninvasive imaging in support of efforts \n                regarding other genotype and phenotypes of Down \n                syndrome.\n                    ``(J) Pharmacological and other therapies for \n                common features of Down syndrome including Alzheimer's \n                disease and other Down syndrome-related disorders.\n                    ``(K) Research related to improving the quality of \n                life for individuals with Down syndrome and their \n                families.\n                    ``(L) Research training programs aimed at \n                increasing the numbers of scientists who are trained to \n                carry out these research directions.\n            ``(3) Services for patients.--\n                    ``(A) In general.--A center receiving funds under \n                paragraph (1) shall expend amounts provided under such \n                paragraph to carry out a program to make individuals \n                aware of opportunities to participate as subjects in \n                research conducted by the centers receiving funds under \n                such paragraph.\n                    ``(B) Referrals and costs.--A program under \n                subparagraph (A) shall, in accordance with such \n                criteria as the Director of NIH may establish, provide \n                to the subjects described in such subparagraph \n                referrals for health and other services and such \n                patient care costs as are required for research.\n                    ``(C) Availability and access.--In awarding grants \n                under this section, the Director of NIH shall require \n                the applicant to demonstrate, and shall take into \n                consideration, the availability of and access to health \n                and medical services described in subparagraph (B).\n            ``(4) Training program for clinicians and scientists.--Each \n        center receiving funds under paragraph (1) shall establish or \n        expand training programs for medical and allied health \n        clinicians and scientists in research relevant to Down \n        syndrome.\n            ``(5) Coordination of centers; reports.--The Director of \n        NIH shall--\n                    ``(A) provide for the coordination of information \n                sharing among the centers receiving funds under \n                paragraph (1) and ensure regular communication among \n                such centers; and\n                    ``(B) require the centers to submit periodic \n                reports to the Director on their activities.\n            ``(6) Organization of centers.--Each center receiving funds \n        under paragraph (1) shall use the facilities of a single \n        institution meeting such requirements as may be prescribed by \n        the Director of NIH, be formed from a virtual consortium or \n        network of such institutions, or both.\n            ``(7) Duration of support.--\n                    ``(A) In general.--Subject to subparagraph (B), the \n                Director of NIH may not provide support to a center \n                receiving funds under paragraph (1) for a period of \n                more than 5 years.\n                    ``(B) Extension.--The period referred to in \n                subparagraph (A) may be extended for 1 or more \n                additional periods not exceeding 5 years if--\n                            ``(i) the operations of the center have \n                        been reviewed by an appropriate technical and \n                        scientific peer review group established by the \n                        Director of NIH; and\n                            ``(ii) such group has recommended to the \n                        Director that such period be extended.\n    ``(c) Down Syndrome Consortium.--In carrying out subsection (a)(1), \nthe Director of NIH may establish a Down Syndrome Consortium to \nfacilitate the exchange of information and to make the research effort \non Down syndrome more efficient and effective by assuring consistent \ncommunication, minimizing duplication of effort, and integrating the \nvaried perspectives of partner agencies, organizations, and \nindividuals.\n    ``(d) Report to Congress.--Not later than January 1, 2012, and each \nJanuary 1 thereafter, the Secretary of Health and Human Services shall \nprepare and submit to the appropriate committees of the Congress a \nreport concerning the implementation of this section.\n    ``(e) Authorization of Appropriations.--To carry out this section, \nthere are authorized to be appropriated $6,000,000 for each of fiscal \nyears 2012 through 2017.''."
}